A clinical study of two formulations, Abhayarishta Churna internally and Aragwadha patra Lepa externally in patients with Kitibha Kushta (psoriasis).

AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE COMBINED EFFECTIVENESS OF ORAL ADMINISTRATION OF ABHAYARISHTA CHURNA AND ARAGWADHA PATRA LEPA IN KITIBHA KUSHTA (PSORIASIS) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059880

Enrollment

Registered

2023-11-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects suffering with Kitibha Kushta less than 1 year of chronicity 2. Subjects of either gender, aged between 18-60 years 3. Subjects willing to participate in the study and ready to sign informed consent form

Exclusion criteria

Exclusion criteria: 1. Uncontrolled diabetes mellitus (HbA1C >7mg/dl) 2. Pregnant women 3. Lactating mother 4. Subjects with impaired cardiac, renal, and hepatic functions

Design outcomes

Primary

Measure	Time frame
? The activity of disease will be assessed by Psoriasis Area Severity Index Score (PASI)Timepoint: on 0th day, 16th day and 31st day	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Lakshmiprasad L Jadhav

Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital, Hassan, Karnataka

sooryajadhav@gmail.com9886614116

Outcome results